In a rare move, the FDA will hold a hearing today to allow a drug company to present its case to keep its Cancer drug approved for terminal Breast Cancer patients.

The hearing comes after an FDA advisory panel proposed to revoke approval for such patients, saying drug risks outweigh any benefits for those patients.

Thousands of women say it has kept them alive, but a similar number have died while taking it.